CVS is the largest US pharmacy with $171.6 billion in sales and a 25.1% market share, per a Drug Channel Institute report in June
PMID 41489681
Weight Loss Outcomes: Clinical Trial Data and Real-World Results Pivotal trials for tirzepatide (SURMOUNT program) demonstrated average weight loss ranging from 16% to 21% of baseline body weight across three dose levels over 68 weeks
If you're taking GLP-1 medicines alongside insulin or sulfonylureas, it's important to check your blood glucose levels when experiencing headaches, as hypoglycaemia (low blood sugar) can also cause headache symptoms
What was needed was a molecule like GLP-1, something that would bind to the same receptorwhat we call a receptor agonist, like getting a slightly different key that opens the same lockbut that would stick around longer and be better tolerated
In rare cases, TRT may increase the risk of heart disease or blood clots, though this is still a topic of ongoing research